GLOW70 — CP-3 Composite
GHK-Cu / BPC-157 / TB-500 Blend · 70mg Research Vial
Available Formats
Vial
Lyophilised powder vial containing all three compounds. Full flexibility in reconstitution.
Cartridge (Reusable Pen)
Pre-filled replacement cartridge compatible with standard reusable research pens. Pen sold separately.
Disposable Pen
Fully pre-loaded, self-contained research pen. Ready to use directly from packaging.
Compound Overview
The GLOW70 CP-3 is a three-component research composite combining GHK-Cu, BPC-157, and Thymosin Beta-4 Fragment (TB-500) into a single preparation. Each constituent has been independently studied in the published literature:
GHK-Cu (Glycyl-L-Histidyl-L-Lysine Copper(II)): A naturally occurring tripeptide-copper chelate first isolated from human plasma (Pickart & Thaler, 1973). Investigated in research for its role in extracellular matrix modulation and copper-dependent enzyme cofactor delivery.
BPC-157 (Body Protection Compound-157): A synthetic pentadecapeptide derived from a sequence within human gastric juice protein. Studied in preclinical research models for its interaction with nitric oxide (NO) systems, growth factor signalling pathways, and tissue remodelling processes (Sikiric et al., 2018).
TB-500 (Thymosin Beta-4 Fragment 17-23): A synthetic fragment of Thymosin Beta-4, a 43-amino-acid peptide involved in actin sequestration and cytoskeletal regulation. TB-500 contains the actin-binding domain and has been studied in preclinical models for its role in cell migration and extracellular matrix interactions.
Published Research
- Pickart L, Thaler MM (1973) — Nature New Biology, 243: 85-87. Identification of GHK as a plasma-derived growth-modulating factor.
- Sikiric P et al. (2018) — Current Pharmaceutical Design, 24(18): 1952-1962. Review of BPC-157 research across preclinical models.
- Goldstein AL et al. (2005) — Expert Opinion on Biological Therapy, 5(8): 1053-1069. Review of Thymosin Beta-4 biology and research applications.
Note: Citations are provided for reference purposes only. BioCompounds UK does not make therapeutic claims based on published research data.
Structural & Chemical Data
| Compound Class | Multi-peptide research composite |
| Components | GHK-Cu + BPC-157 + TB-500 |
| Purity | >99% verified by HPLC (per component) |
| Form | Lyophilised powder (vial) / Pre-filled solution (cartridge & pen) |
| Solubility | Sterile water / PBS |
| Storage (Dry) | -20 C |
| Storage (Reconstituted) | 2-8 C, use within 4 weeks |
Regulatory & Usage Notice
This product is supplied strictly as a research-grade reference compound for in-vitro laboratory investigation only. It is not approved, intended, or marketed for human or veterinary administration, diagnostic purposes, or therapeutic application. Purchasers must be qualified researchers aged 18+ and agree to handle all compounds in accordance with applicable regulations and good laboratory practice (GLP). BioCompounds UK makes no therapeutic claims regarding this or any compound in its catalogue.
Both product and service were excellent
outstanding
Good products and advice.. excellent service